• News
  • Second HONEUR Newsletter!
    21/12/2022

    HONEUR has sent out its second HONEUR Newsletter! In this Winter 2022 edition:

    • 21 HONEUR data partners
    • Evidence generation projects, with a focus on our Landmark study
      • Read more
  • New HONEUR Forum date: 25-26 MAY 2023!
    10/12/2022

    In light of the success of our very first HONEUR Forum meeting on 23 September 2022, we are happy to announce the date of the second HONEUR Forum meeting: 25-26 MAY 2023!

    We are inviting all ou... Read more

  • HONEUR mapping progress: 56.000 patients mapped!
    25/11/2022

    We are proud to share with you that we currently have over 56.000 patients from 12 HONEUR sites mapped in the HONEUR network. Nearly 43.000 of these are multiple myeloma patients. Of the total number of mapped patient ... Read more

  • 21st HONEUR Data Partner: Cardiff and Vale!
    15/11/2022

    A warm welcome to our 21st HONEUR Data Partner: Cardiff and Vale! Cardiff and Vale University Health Board includes the University Hospital of Wales and has strong links to Cardiff University. UHW is a large 900 bed te... Read more

  • HONEUR abstract at ASH 2022!
    13/10/2022

    We are excited to inform you that our study abstract on lenalidomide exposed RRMM patients has been accepted for poster presentation at the 64th annual ASH Conference in December 2022! Using real-world data from two HO... Read more

ITEM CODE: RF-247386 | DATE OF PREPARATION: NOVEMBER 2022